Blood Pressure Control versus Atrial Fibrillation Management in Stroke Prevention

Carmine Savoia, Lidia Sada, Massimo Volpe

Research output: Contribution to journalArticlepeer-review


Hypertension is one of the major risk factors for atrial fibrillation which in turn is the most prevalent concomitant condition in hypertensive patients. While both these pathological conditions are independent risk factors for stroke, the association of hypertension and atrial fibrillation increases the incidence of disabling strokes. Moreover, documented or silent atrial fibrillation doubles the rate of cardiovascular death. Lowering blood pressure is strongly recommended, particularly for primary stroke prevention. However, a relatively small percentage of hypertensive patients still achieve the recommended blood pressure goals. The management of atrial fibrillation with respect to stroke prevention is changing. New oral anticoagulants represent a major advancement in long-term anticoagulation therapy in non valvular atrial fibrillation. They have several benefits over warfarin, including improved adherence to the anticoagulation therapy. This is an important issue since non-adherence to stroke prevention medications is a risk factor for first and recurrent strokes.

Original languageEnglish
JournalCurrent Hypertension Reports
Issue number6
Publication statusPublished - Jun 1 2015


  • Antihypertensive drugs
  • ARBs
  • Blood pressure control
  • NOACs
  • Oral anticoagulants

ASJC Scopus subject areas

  • Internal Medicine
  • Medicine(all)


Dive into the research topics of 'Blood Pressure Control versus Atrial Fibrillation Management in Stroke Prevention'. Together they form a unique fingerprint.

Cite this